Avricore Health Inc V.AVCR

Alternate Symbol(s): AVCRF

Healthcare Diagnostics & Research

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

TSXV:AVCR - Post by User

Avricore Health Inc > Q3 results

<< Previous

Bullboard Posts

Comment by lscfaon Nov 29, 2024 1:35pm

29 Views

Post# 36337883

RE:RE:RE:RE:Q3 results

Expanded table

Qtr ending	SBC	Net income (loss)	CFO
Q3 24	338,089	(179,015)	274,806
Q2 24	1,598	54,022	145,038
Q1 24	27,464	168,537	317,806
Q4 23	142,765	59,584	339,420
Q3 23	304,328	(285,062)	139,684
Q2 23	168,518	(284,225)	(26,787)
Q1 23	88,001	(191,512)	(25,259)
Q4 22	243,000	(244,769)	84,908
Q3 22	58,354	(180,398)	(46,671)
Q2 22	9,069	(207,383)	(176,229)
Q1 22	21,099	(185,678)	(157,000)